top of page
Independent National Cancer Advisory Group
Terms of reference, minutes of the first meeting and membership are now available for this Group, whose role is to advise and assess on...
Clinical Nurse Specialist Report
Available from 6th December 2016 to mark the Cancer52 session at Britain Against Cancer - a new report from Cancer52 on the role of the...
My Cancer My DNA - Genetic Alliance patient charter
Cancer52 is working with Genetic Alliance on its patient charter, My Cancer My DNA. Genetic Alliance today (8 March) has launched its new...
Cancer52 - partner in Genetic Alliance project
Cancer52 has become a partner in Genetic Alliance's 'My Cancer, My DNA' project, together with Cancer Research UK, Bloodwise and Breast...
New paper published that looks at diagnosis challenges for rarer cancers
A new study, published today (26 February) looks at the challenges of timely diagnosis for people with rarer cancers. Authored by Silvia...
Cancer 52 Position Paper on Access to Medicines and Treatments
Cancer52 has published a position paper 'Cancer 52 Position Paper on Access to Medicines and Treatments' which gives a clear view on the...
Cancer52 at Britain Against Cancer
Available for the first time at Britain Against Cancer on 8 December are two new briefings from Cancer52: "Living with a rare or less...
Stopgap donate to Cancer52
Our thanks to Stopgap who have donated £400 to Cancer52. Stopgap is a small (50 people) owner managed business which finds marketing...
Radio 4 Inside Health interview
Chair Jonathan Pearce is interviewed on BBC Radio 4's Inside Health Programme on the Cancer Drug Fund and the extra challenges faced by...
In response to the National Audit Offices Investigation into Cancer Drugs Fund report
Jonathan Pearce, Chair of Cancer52, said: "Cancer52 calls on NHS England to learn from The National Audit Office’s report[1] and ensure...
bottom of page